Clinical Trials

Carcinoma, Hepatocellular

NCT03139916 2024-05-16

Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

36 enrolled 11 charts

CNS

Glioblastoma

NCT05249569 2023-05-03

Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma

Phase 2 Terminated

1 enrolled 4 charts

Carcinoma, Hepatocellular

NCT04099641 2023-02-08

An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients

80 enrolled 14 charts

Stomach Neoplasms

NCT01264705 2020-11-12

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

Phase 1/2 Completed

47 enrolled 10 charts

Fibrosis, Gastrointestinal Neoplasms, Hepatitis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT01634685 2020-08-20

A Phase I Study of Bavituximab, Capecitabine, and Radiation for the Treatment of Rectal Adenocarcinoma

15 enrolled

Rectal Neoplasms

NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Phase 1 Withdrawn

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT01323062 2018-12-04

Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects

26 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01335204 2018-07-13

Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer

Phase 1/2 Terminated

4 enrolled 5 charts

Genitourinary

Prostatic Neoplasms

NCT02651610 2017-07-11

Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms

NCT00669591 2017-04-21

A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer

46 enrolled

Breast Neoplasms

NCT01999673 2017-04-21

SUNRISE

Phase 3 Completed

582 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01138163 2017-04-19

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

121 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01160601 2017-04-19

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

86 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01272791 2017-04-19

Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer

70 enrolled

Pancreatic Neoplasms

NCT02685306 2017-03-09

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02673814 2016-08-01

Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT01288261 2016-04-21

Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer

14 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT00669565 2011-03-24

Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

46 enrolled

Breast Neoplasms

NCT00687817 2011-03-24

Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer

49 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00129337 2011-03-01

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies